Human Platelet Lysate as a Functional Substitute for Fetal Bovine Serum in the Culture of Human Adipose Derived Stromal/Stem Cells

被引:34
|
作者
Cowper, Mathew [1 ,7 ]
Frazier, Trivia [1 ,2 ,3 ]
Wu, Xiying [2 ,3 ]
Curley, J. Lowry [2 ,4 ]
Ma, Michelle H. [3 ]
Mohiuddin, Omair A. [1 ]
Dietrich, Marilyn [5 ]
McCarthy, Michelle [1 ]
Bukowska, Joanna [1 ,6 ]
Gimble, Jeffrey M. [1 ,2 ,3 ]
机构
[1] Tulane Univ, Sch Med, New Orleans, LA 70112 USA
[2] LaCell LLC, New Orleans, LA 70148 USA
[3] Obatala Sci Inc, New Orleans, LA 70148 USA
[4] Axosim Inc, New Orleans, LA 70112 USA
[5] Louisiana State Univ, Sch Vet Med, Baton Rouge, LA 70803 USA
[6] Polish Acad Sci, Inst Anim Reprod & Food Res, PL-10748 Olsztyn, Poland
[7] Wake Forest Univ, Bowman Gray Sch Med, Dept Urol, Winston Salem, NC 27101 USA
关键词
adipogenesis; adipose-derived stromal/stem cells; chondrogenesis; colony forming unit-fibroblast; fetal bovine serum; human platelet lysate; mesenchymal stem cell; osteogenesis; regenerative medicine; MESENCHYMAL STEM-CELLS; VASCULAR FRACTION; COLONY FORMATION; EXPANSION; DIFFERENTIATION; PROLIFERATION; SECRETOME;
D O I
10.3390/cells8070724
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Introduction: Adipose derived stromal/stem cells (ASCs) hold potential as cell therapeutics for a wide range of disease states; however, many expansion protocols rely on the use of fetal bovine serum (FBS) as a cell culture nutrient supplement. The current study explores the substitution of lysates from expired human platelets (HPLs) as an FBS substitute. Methods: Expired human platelets from an authorized blood center were lysed by freeze/thawing and used to examine human ASCs with respect to proliferation using hematocytometer cell counts, colony forming unit-fibroblast (CFU-F) frequency, surface immunophenotype by flow cytometry, and tri-lineage (adipocyte, chondrocyte, osteoblast) differentiation potential by histochemical staining. Results: The proliferation assays demonstrated that HPLs supported ASC proliferation in a concentration dependent manner, reaching levels that exceeded that observed in the presence of 10% FBS. The concentration of 0.75% HPLs was equivalent to 10% FBS when utilized in cell culture media with respect to proliferation, immunophenotype, and CFU-F frequency. When added to osteogenic, adipogenic, and chondrogenic differentiation media, both supplements showed appropriate differentiation by staining. Conclusion: HPLs is an effective substitute for FBS in the culture, expansion and differentiation of human ASCs suitable for pre-clinical studies; however, additional assays and analyses will be necessary to validate HPLs for clinical applications and regulatory approval.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Human platelet lysate as a fetal bovine serum substitute improves human adipose-derived stromal cell culture for future cardiac repair applications
    B. A. Naaijkens
    H. W. M. Niessen
    H-J. Prins
    P. A. J. Krijnen
    T. J. A. Kokhuis
    N. de Jong
    V. W. M. van Hinsbergh
    O. Kamp
    M. N. Helder
    R. J. P. Musters
    A. van Dijk
    L. J. M. Juffermans
    Cell and Tissue Research, 2012, 348 : 119 - 130
  • [2] Human platelet lysate as a fetal bovine serum substitute improves human adipose-derived stromal cell culture for future cardiac repair applications
    Naaijkens, B. A.
    Niessen, H. W. M.
    Prins, H-J
    Krijnen, P. A. J.
    Kokhuis, T. J. A.
    de Jong, N.
    van Hinsbergh, V. W. M.
    Kamp, O.
    Helder, M. N.
    Musters, R. J. P.
    van Dijk, A.
    Juffermans, L. J. M.
    CELL AND TISSUE RESEARCH, 2012, 348 (01) : 119 - 130
  • [3] Senescence and quiescence in adipose-derived stromal cells: Effects of human platelet lysate, fetal bovine serum and hypoxia
    Sondergaard, Rebekka Harary
    Follin, Bjarke
    Lund, Lisbeth Drozd
    Juhl, Morten
    Ekblond, Annette
    Kastrup, Jens
    Haack-Sorensen, Mandana
    CYTOTHERAPY, 2017, 19 (01) : 95 - 106
  • [4] Differences between the Proliferative Effects of Human Platelet Lysate and Fetal Bovine Serum on Human Adipose-Derived Stem Cells
    Kakudo, Natsuko
    Morimoto, Naoki
    Ma, Yuanyuan
    Kusumoto, Kenji
    CELLS, 2019, 8 (10)
  • [5] Evaluation of human platelet lysate versus fetal bovine serum for culture of mesenchymal stromal cells
    Hemeda, Hatim
    Giebel, Bernd
    Wagner, Wolfgang
    CYTOTHERAPY, 2014, 16 (02) : 170 - 180
  • [6] Platelet lysate as substitute for fetal calf serum in the culture of stem cells derived from adipose tissue and amniotic membrane
    Peterbauer, A.
    Aberl, J.
    Muellegger, D.
    Schauer, K.
    Stadler, G.
    Lindenmair, A.
    Gabriel, C.
    Redl, H.
    van Griensven, M.
    Wolbank, S.
    TISSUE ENGINEERING PART A, 2008, 14 (05) : 896 - 896
  • [7] SUBSTITUTION OF FETAL CALF SERUM BY PLATELET LYSATE FOR CULTURE OF ADIPOSE DERIVED STEM CELLS
    Peterbauer-Scherb, A.
    Hildner, F.
    Aberl, J.
    Muellegger, D.
    Gabriel, C.
    Redl, H.
    van Griensven, M.
    Wolbank, S.
    VOX SANGUINIS, 2010, 99 : 475 - 475
  • [8] Human platelet lysate as a replacement for fetal bovine serum in human corneal stromal keratocyte and fibroblast culture
    Seidelmann, Nina
    Campos, Daniela F. Duarte
    Rohde, Malena
    Johnen, Sandra
    Salla, Sabine
    Yam, Gary Hin-Fai
    Mehta, Jodhbir S.
    Walter, Peter
    Fuest, Matthias
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (20) : 9647 - 9659
  • [9] Serum-converted platelet lysate can substitute for fetal bovine serum in human mesenchymal stromal cell cultures
    Mojica-Henshaw, Mariluz P.
    Jacobson, Pam
    Morris, Julie
    Kelley, Linda
    Pierce, Jan
    Boyer, Michael
    Reems, Jo-Anna
    CYTOTHERAPY, 2013, 15 (12) : 1458 - 1468
  • [10] Human platelet lysate as an alternative to fetal bovine serum for culture and endothelial differentiation of human amniotic fluid mesenchymal stem cells
    Tancharoen, Waleephan
    Aungsuchawan, Sirinda
    Pothacharoen, Peraphan
    Bumroongkit, Kanokkan
    Puaninta, Chaniporn
    Pangjaidee, Nathaporn
    Narakornsak, Suteera
    Markmee, Runchana
    Laowanitwattana, Tanongsak
    Thaojamnong, Chawapon
    MOLECULAR MEDICINE REPORTS, 2019, 19 (06) : 5123 - 5132